Cognitive effects of nicotine

Biological Psychiatry

Volumn 49, Issue 3, 2001, Pages 258-267

  Rezvani, Amir H ^a   Levin, Edward D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

AD; ADHD; Attention; Cognition; Memory; Nicotine

Indexed keywords

3 METHYL 5 (1 METHYL 2 PYRROLIDINYL)ISOXAZOLE; AMPHETAMINE; HALOPERIDOL; METHYLPHENIDATE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; RECEPTOR SUBUNIT;

ADOLESCENT; ADULT; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL SKIN REACTION; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HIPPOCAMPUS; HUMAN; HYPERACTIVITY; LONG TERM EXPOSURE; MALE; NAUSEA; NONHUMAN; PRIORITY JOURNAL; RAT; REACTION TIME; SCHIZOPHRENIA; TRANSDERMAL PATCH; TREATMENT OUTCOME; VERTIGO; WORKING MEMORY;

EID: 0035251680     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(00)01094-5     Document Type: Review

References (95)

1. Normalization of auditory physiology by cigarette smoking in schizophrenic patients
2. Nicotine enhances the learning and memory of aged rats
3. Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21
4. Neurobiology and clinical pathophysiology of neuronal nicotinic acetylcholine receptors
5. Nicotinic receptor agonists facilitate retention of avoidance training - Participation of dopaminergic mechanisms
6. Autoradiographic distribution of nicotine receptors in rat brain
7. Effects of post-learning smoking on memory consolidation
8. Nicotine and attention in adult ADHD
9. Alzheimer's disease: A disorder of cholinergic innervation
10. Spatial working memory enhancement by nicotine of aged Long-Evans rats in the T-maze
11. Cigarette smoking and neuroleptic-induced Parkinsonism
12. Diversity of neuronal nicotinic acetylcholine receptors: Lessons from behavior and implications for CNS therapeutics - Minireview
13. Effects of ABT-418, a novel cholinergic channel ligand, on place learning in septal-lesioned rats
14. Effects of lobeline, a nicotinic receptor agonist, on learning and memory
15. Proactive interference effects on short-term memory in rats: 1. Basic parameters and drug effects
16. Nicotinic antagonist administration into the ventral hippocampus and spatial working memory in rats
17. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia
18. Alpha-Bungarotoxin binding to hippocampal interneurons - Immunocytochemical characterization and effects on growth factor expression
19. The cholinergic receptor system in the frontal lobe of Alzheimer's patients
20. Hippocampal synaptic transmission enhanced by low concentrations of nicotine
21. 6-OHDA lesions of the nucleus accumbens accentuate memory deficits in animals with lesions to the forebrain cholinergic projection system: Effects of nicotine administration on learning and memory in the water maze
22. Are the cognitive-enhancing effects of nicotine in the rat with lesions to the forebrain cholinergic projection system mediated by an interaction with the noradrenergic system?
23. Nicotine induces long-lasting potentiation in the dentate gyrus of nicotine-primed rats
24. The effects of varying cigarette deprivation duration on cognitive and performance tasks
25. Nicotine and smoking: A review of effects on human performance
26. Prevalence of smoking among psychiatric outpatients
27. What does the hippocampus really do?
28. Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease
29. Nicotinic cholinergic receptors in Alzheimer's disease
30. Nicotinic, muscarinic and dopaminergic actions in the ventral hippocampus and the nucleus accumbens: Effects on spatial working memory in rats
31. Nicotinic receptor function in schizophrenia
32. Nicotine systems and cognitive function
33. AR-R 17779, an a7 nicotinic agonist improves learning and memory in rats
34. Chronic nicotinic stimulation and blockade effects on working memory
35. Chronic nicotinic agonist and antagonist effects on T-maze alternation
36. Chronic nicotine-induced improvement of spatial working memory and D2 dopamine effects in rats
37. Chronic nicotine reverses working memory deficits caused by lesions of the fimbria or medial basalocortical projection
38. Ventral hippocampal ibotenic acid lesions block chronic nicotine-induced spatial working memory improvement in rats
39. Transdermal nicotine effects on attention
40. Nicotine effects on adults with attention-deficit/hyperactivity disorder
41. Bridged nicotine, isonicotine, and norisonicotine effects on working memory performance of rats in the radial-arm maze
42. Acute nicotine interactions with nicotinic and muscarinic antagonists: Working and reference memory effects in the 16-arm radial maze
43. Chronic nicotine effects on working and reference memory in the 16-arm radial maze: Interactions with D1 agonist and antagonist drugs
44. Chronic nicotine and withdrawal effects on radial-arm maze performance in rats
45. Development of nicotinic drug therapy for cognitive disorders
46. Anticholinergic sensitivity following chronic nicotine administration as measured by radial-arm maze performance in rats
47. Effects of nicotinic dimethylaminoethyl esters on working memory performance of rats in the radial-arm maze
48. Nicotinic acetylcholine involvement in cognitive function in animals
49. Nicotine effects and attention deficit disorder
50. Epibatidine, a potent nicotinic agonist: Effects on learning and memory in the radial-arm maze
51. Nicotine effects on memory performance
52. Acute and chronic nicotine effects on working memory in aged rats
53. Nicotine-haloperidol interactions and cognitive performance in schizophrenics
54. Nicotine binding sites and their localization in the central nervous system
55. Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron
56. Nicotinic system involvement in Alzheimer's and Parkinson's diseases: Implications for therapeutics
57. Intravenous nicotine in Alzheimer's disease: A pilot study
58. Clinical studies in Alzheimer patients with positron emission tomography
59. Imaging of nicotinic receptors in human brain
60. Change in nicotinic receptor subtypes in temporal cortex of Alzheimer brains
61. Blockade of hippocampal nicotinic receptors impairs working memory but not reference memory in rats
62. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's Disease: Selectivity toward human brain acetylcholinesterase compared with butyrylcholinestrase
63. Increased regional cerebral glucose metabolism and semantic memory performance in Alzheimer's disease: A pilot double blind transdermal nicotine positron emission tomography study
64. Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases
65. Neurotransmitter and receptor deficits in senile dementia of the Alzheimer's type
66. Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension
67. Learning impairment following lesion of basal nucleus of Meynert in the marmoset: Modification by cholinergic drugs
68. A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease
69. Effect of nicotine and nicotinic receptor agonists on latent inhibition in the rat
70. Effortful processing is a requirement for nicotine-induced improvement in memory
71. Effects of post-trial administration of nicotine on human memory: Evaluating the conditions for improving memory
72. The effects of nicotine on attention, information processing, and working memory in patients with dementia of the Alzheimer type
73. Nicotine inhibits amyloid formation by the beta-peptide
74. Experimental approaches to cognitive disturbance in Alzheimer's disease
75. Nicotine improves cognitive disturbance in rodents fed with a choline-deficient diet
76. Nicotinic receptors in Alzheimer's disease
77. Autoradiographic distribution of high affinity muscarinic and nicotinic cholinergic receptors labled with [3H] acetylcholine in rat brain
78. Changes in nicotinic and muscarinic receptors in Alzheimer-type dementia
79. The effcts of nicotine in dermal plaster on cognitive functions in patients with Alzheimer's disease
80. Nicotine enhances Morris water maze performance of young and aged rats
81. Serotonin and acetylcholine release response in the rat hippocampus during a spatial memory task
82. Treatment of central nervous system degenerative disorders
83. Nicotinic acetylcholine receptor subtypes in human frontal cortex: Changes in Alzheimer's disease
84. A 5-month, randomized, placebo-controlled trial of galantamine in AD
85. Cholinergic channel activator, ABT-418, enhances delayed-response accuracy in rats
86. Effects of stimulation or blockade of central nicotinic-cholinergic receptors on performance of a novel version of the rat stimulus discrimination task
87. Evaluation of the information processing and mood effects of a transdermal nicotine patch
88. Improvements in performance without nicotine withdrawal
89. Four week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease
90. A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder
91. Effects of cigarette smoking on immediate memory and performance in different kinds of smoker
92. Nicotine patches in Alzheimer's disease: Pilot study on learning,memory, and safety
93. Presynaptic nicotinic ACh receptors
94. Presynaptic modulation of transmitter release by nicotinic receptors
95. Effects of nicotine on memory retrieval in mice